In contrast, ADAMTS13 activity decreased in patients with acute-on-chronic liver failure, acute liver failure/acute liver injury, and sepsis (Figure 2B), resulting in a decline in ADAMTS13-specific activity proportional to disease severity (Figure 2C), indicating reduced enzymatic capacity in the most critically ill patients. The gene discussed is ADAMTS13; the disease is acute-on-chronic liver failure.